Insolvent drug Zolgensma 167 million yen covered by insurance at 13:39, the highest in Japan
Chuikyo, the Central Social Insurance Medical Council, targets insurance coverage for "Zolgensma," which is said to be the "highest in the world," for intractable diseases such as young children, and costs about 167 million yen per time. Approved to be a circle. It is the most expensive drug covered by insurance in Japan.
Zorgensuma is a drug for treating intractable disease "spinal muscular atrophy" in young children and other patients with weakened muscles throughout the body, and was approved by the government in March this year.
It is said to be the "highest drug in the world", with more than 200 million yen per dose in the United States.
Regarding this medicine, Chuikyo held a general meeting on the 13th to approve the target price of 167.70 million yen after applying it to the public medical insurance.
Until now, the highest drug covered by insurance in Japan was 33.49 million yen for the drug Leukemia and other drugs "Kimria", which was significantly higher than that for "Zolgensma".
The target patients are children under the age of 2 and the number of patients is expected to be about 25 per year.
Self-pay on the part of the patient is expected to be almost non-existent due to subsidies from the national and local governments for incurable diseases and medical expenses for children.